Evidence map›Paper›PMID 40285168›Full record

ArticleSensors (Basel, Switzerland)2025

Boosting Skin Cancer Classification: A Multi-Scale Attention and Ensemble Approach with Vision Transformers.

Guang Yang, Suhuai Luo, Peter Greer

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. [Synergistic learnable frequency and multi-scale spatial network for lightweight skin cancer classification].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guang YangSchool of Information and Physical Sciences, The University of Newcastle, Callaghan, NSW 2308, Australia.ORCID 0000-0002-6747-6121
Suhuai LuoSchool of Information and Physical Sciences, College of Engineering, Science and Environment, The University of Newcastle, Callaghan NSW 2308, Australia.
Peter GreerSchool of Information and Physical Sciences, College of Engineering, Science and Environment, The University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0001-7494-4029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is a significant global health concern, with melanoma being the most dangerous form, responsible for the majority of skin cancer-related deaths. Early detection of skin cancer is critical, as it can drastically improve survival rates. While deep learning models have achieved impressive results in skin cancer classification, there remain challenges in accurately distinguishing between benign and malignant lesions. In this study, we introduce a novel multi-scale attention-based performance booster inspired by the Vision Transformer (ViT) architecture, which enhances the accuracy of both ViT and convolutional neural network (CNN) models. By leveraging attention maps to identify discriminative regions within skin lesion images, our method improves the models' focus on diagnostically relevant areas. Additionally, we employ ensemble learning techniques to combine the outputs of several deep learning models using majority voting. Our skin cancer classifier, consisting of ViT and EfficientNet models, achieved a classification accuracy of 95.05% on the ISIC2018 dataset, outperforming individual models. The results demonstrate the effectiveness of integrating attention-based multi-scale learning and ensemble methods in skin cancer classification.

Indexed as

MelanomaSkin NeoplasmsAlgorithmsAttentionDeep LearningHumansNeural Networks, Computerdeep learningimage processingneural networksskin cancer classificationtransformer

Identifiers

PMID40285168
PMCPMC12030980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.